Pesticides & Agrochemicals · Founded 2007 · www.novaagri.in · BSE 544100 · NSE NOVAAGRI · ISIN INE02H701025
No Notes Added Yet
Business
Nova Agritech Ltd. is an Indian company engaged in the manufacturing, formulation, and marketing of a wide range of agricultural inputs. Its core business revolves around providing crop protection products (such as pesticides, insecticides, fungicides, and herbicides), crop nutrition products (like micronutrients, plant growth regulators, and bio-stimulants), and soil health products. The company operates on an integrated model, focusing on research and development to create effective solutions for farmers, which are then manufactured and distributed through its network. Nova Agritech aims to enhance crop yield and quality by offering comprehensive agricultural solutions. It generates revenue primarily through the sale of these products to farmers, dealers, and distributors across various agricultural regions.
Revenue Mix
Nova Agritech's business segments primarily include:
Crop Protection Products: This segment covers pesticides, insecticides, fungicides, and herbicides designed to protect crops from pests and diseases.
Crop Nutrition Products: This segment offers micronutrients, plant growth regulators, and other nutrient-based products to improve plant health and yield.
Soil Health Products: Products aimed at improving soil fertility and structure.
Specific revenue contributions for each segment are not readily available without financial statements, but agrochemical companies often see crop protection as a significant contributor.
Industry
The Pesticides & Agrochemicals industry in India is characterized by its dependence on monsoons, raw material price volatility, and evolving regulatory landscape. It is a competitive industry with a mix of large multinational players, established domestic companies, and numerous smaller regional players. Nova Agritech likely positions itself as an integrated player offering a diverse portfolio of products across crop protection, nutrition, and soil health categories. Its standing is likely that of a growing domestic manufacturer aiming to expand its market presence and distribution reach amidst a fragmented market.
MOAT
For a company like Nova Agritech, potential competitive advantages, which may be developing rather than fully established "moats," could include:
Integrated Operations: In-house R&D, manufacturing, and formulation capabilities can lead to cost efficiencies and quality control.
Diversified Product Portfolio: Offering a broad range of products across different categories reduces dependence on any single product and caters to varied farmer needs.
Distribution Network: Building a robust sales and distribution network, especially in specific agricultural belts, can be a localized advantage in reaching farmers.
Farmer Connect & Brand Building: Developing trust and recognition among farming communities through product effectiveness and localized marketing efforts.
Growth Drivers
Increased Agricultural Production: Growing demand for food due to population growth drives the need for enhanced agricultural output, requiring more inputs.
Modernization of Agriculture: Increasing adoption of advanced farming techniques and high-quality inputs by Indian farmers.
Product Innovation & Portfolio Expansion: Launching new, effective, and environmentally friendly formulations to address evolving pest challenges and nutrient deficiencies.
Expansion of Distribution Network: Penetrating new geographic markets and strengthening existing channels to reach a larger farmer base.
Government Initiatives: Supportive government policies for agriculture, including subsidies for inputs and efforts to boost farm income.
Crop Diversification: Shift towards higher-value crops often requires more specialized agrochemical inputs.
Risks
Monsoon Dependence: The performance of the Indian agricultural sector is highly reliant on adequate and timely monsoons, directly impacting demand for agrochemicals.
Raw Material Price Volatility: Fluctuations in the prices of key chemical intermediates and crude oil can impact manufacturing costs and margins.
Regulatory Changes: Strict environmental regulations, bans on certain chemicals, or new registration requirements can impact product portfolio and operations.
Intense Competition: The presence of numerous domestic and international players leads to pricing pressure and market share battles.
Counterfeit Products: The proliferation of counterfeit agrochemicals can erode brand value and market share.
Pest Resistance: Continuous need for R&D to develop new solutions as pests develop resistance to existing chemicals.
Product Failure/Recall: Any issues with product efficacy or safety could lead to significant reputational and financial damage.
Management & Ownership
Nova Agritech Ltd. is promoted by individuals who are likely the founders or founding family, typical for many Indian companies. Promoter ownership generally signifies alignment with long-term company growth. Management quality would be assessed based on their strategic vision, execution capabilities in product development and market expansion, and financial prudence. The ownership structure usually involves a significant promoter stake, alongside institutional investors and the public post-listing.
Outlook
Nova Agritech operates in an essential sector with underlying tailwinds from a growing population and the need for enhanced food security. The company's integrated approach and diverse product portfolio position it to capitalize on the increasing adoption of modern farming practices in India. Growth could be driven by successful new product introductions, expansion of its distribution network, and an overall increase in agricultural activity. However, the company faces inherent industry challenges, including the unpredictable nature of monsoons, volatile raw material costs, and intense competition, which can impact profitability and market share. Regulatory changes and the continuous need for R&D to stay ahead of pest challenges are also significant factors. The ability of Nova Agritech to innovate, manage costs effectively, and strengthen its distribution will be key to navigating these dynamics and achieving sustainable growth.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 71 | 42 | 83 | 88 | 81 | 47 | 92 | 67 | 56 | 60 |
| Other Income | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 71 | 42 | 83 | 88 | 83 | 47 | 92 | 67 | 56 | 60 |
| Total Expenditure | 61 | 36 | 71 | 73 | 72 | 41 | 80 | 60 | 52 | 54 |
| Operating Profit | 10 | 6 | 12 | 16 | 11 | 5 | 12 | 6 | 4 | 6 |
| Interest | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 2 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 7 | 5 | 10 | 14 | 9 | 4 | 9 | 3 | 1 | 4 |
| Provision for Tax | -1 | 1 | 4 | 3 | 3 | 1 | 3 | 1 | 1 | 1 |
| Profit After Tax | 8 | 4 | 7 | 11 | 6 | 3 | 7 | 3 | 0 | 3 |
| Adjustments | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | 8 | 4 | 7 | 11 | 6 | 3 | 7 | 3 | 0 | 3 |
| Adjusted Earnings Per Share | 0.9 | 0.5 | 0.8 | 1.2 | 0.6 | 0.4 | 0.7 | 0.3 | 0 | 0.4 |
| #(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 116 | 131 | 127 | 161 | 186 | 211 | 252 | 294 | 262 | 275 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
| Total Income | 116 | 131 | 127 | 161 | 186 | 211 | 253 | 297 | 262 | 275 |
| Total Expenditure | 100 | 118 | 113 | 142 | 158 | 172 | 208 | 251 | 234 | 246 |
| Operating Profit | 15 | 13 | 14 | 18 | 28 | 39 | 44 | 45 | 27 | 28 |
| Interest | 3 | 4 | 6 | 8 | 7 | 9 | 9 | 5 | 5 | 4 |
| Depreciation | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 5 | 6 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 10 | 7 | 5 | 9 | 18 | 28 | 33 | 38 | 18 | 17 |
| Provision for Tax | 3 | 3 | 2 | 2 | 5 | 8 | 5 | 11 | 5 | 6 |
| Profit After Tax | 6 | 5 | 3 | 6 | 14 | 20 | 28 | 27 | 13 | 13 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 6 | 5 | 3 | 6 | 14 | 20 | 28 | 27 | 13 | 13 |
| Adjusted Earnings Per Share | 1 | 0.8 | 0.5 | 1 | 2.2 | 3.3 | 3.1 | 3 | 1.4 | 1.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -11% | 7% | 10% | 0% |
| Operating Profit CAGR | -40% | -12% | 8% | 0% |
| PAT CAGR | -52% | -13% | 17% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -54% | NA% | NA% | NA% |
| ROE Average | 6% | 14% | 23% | 23% |
| ROCE Average | 8% | 15% | 21% | 21% |
| #(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 22 | 27 | 23 | 29 | 43 | 64 | 193 | 220 | 233 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 5 | 6 | 15 | 18 | 24 | 16 | 8 | 3 | 2 |
| Other Non-Current Liabilities | 1 | 3 | 1 | 1 | -3 | -3 | -7 | -6 | -5 |
| Total Current Liabilities | 69 | 82 | 89 | 95 | 92 | 99 | 96 | 111 | 109 |
| Total Liabilities | 97 | 118 | 128 | 144 | 156 | 176 | 289 | 329 | 338 |
| Fixed Assets | 15 | 17 | 16 | 17 | 18 | 17 | 16 | 16 | 51 |
| Other Non-Current Assets | 4 | 3 | 1 | 1 | 1 | 1 | 2 | 19 | 0 |
| Total Current Assets | 77 | 99 | 111 | 126 | 137 | 158 | 272 | 294 | 287 |
| Total Assets | 97 | 118 | 128 | 144 | 156 | 176 | 289 | 329 | 338 |
| #(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 63 | 6 |
| Cash Flow from Operating Activities | 3 | 3 | -9 | 5 | 2 | 6 | 1 | -18 | 2 |
| Cash Flow from Investing Activities | -6 | -3 | -1 | -3 | -4 | -2 | -23 | -26 | 1 |
| Cash Flow from Financing Activities | 3 | -1 | 10 | -2 | 3 | -2 | 82 | -12 | -9 |
| Net Cash Inflow / Outflow | -0 | 0 | -0 | 0 | 1 | 2 | 59 | -57 | -6 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 2 | 3 | 63 | 6 | 0 |
| # | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 1.02 | 0.78 | 0.48 | 1 | 2.18 | 3.27 | 3.06 | 2.96 | 1.39 |
| CEPS(Rs) | 1.42 | 1.15 | 0.85 | 1.35 | 2.54 | 3.64 | 3.27 | 3.16 | 1.92 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 3.51 | 4.29 | 3.65 | 4.69 | 6.89 | 10.19 | 20.87 | 23.76 | 25.14 |
| Core EBITDA Margin(%) | 13.15 | 10.14 | 10.74 | 11.31 | 15.01 | 18.5 | 17.55 | 14.51 | 10.45 |
| EBIT Margin(%) | 11.06 | 8.37 | 8.91 | 10.15 | 13.82 | 17.56 | 16.79 | 14.73 | 8.62 |
| Pre Tax Margin(%) | 8.39 | 5.68 | 3.84 | 5.4 | 9.94 | 13.38 | 13.21 | 12.95 | 6.76 |
| PAT Margin (%) | 5.53 | 3.74 | 2.35 | 3.92 | 7.38 | 9.73 | 11.21 | 9.32 | 4.91 |
| Cash Profit Margin (%) | 7.69 | 5.52 | 4.2 | 5.26 | 8.57 | 10.85 | 11.99 | 9.94 | 6.8 |
| ROA(%) | 6.6 | 4.54 | 2.65 | 4.63 | 9.13 | 12.33 | 12.16 | 8.87 | 3.85 |
| ROE(%) | 29.04 | 19.98 | 13.27 | 24.08 | 37.7 | 38.27 | 22.03 | 13.28 | 5.68 |
| ROCE(%) | 24.55 | 19.97 | 18.64 | 21.82 | 27.29 | 30.51 | 21.79 | 16.39 | 8.09 |
| Receivable days | 132.15 | 137.84 | 163.25 | 177.67 | 174.99 | 172.19 | 165.61 | 188.51 | 255.11 |
| Inventory Days | 107.78 | 101.92 | 103 | 82.65 | 71.01 | 68.06 | 65.99 | 70.61 | 106.04 |
| Payable days | 206.85 | 212.57 | 220.03 | 167.58 | 126.74 | 89.88 | 62.04 | 64.76 | 96.98 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 16.53 | 14.41 | 13.33 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 2.42 | 1.8 | 0.74 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.37 | 0.33 | 0.46 | 0.39 | 0.4 | 0.38 | 1.76 | 1.43 | 0.85 |
| EV/Core EBITDA(x) | 2.77 | 3.23 | 4.3 | 3.43 | 2.7 | 2.04 | 10.01 | 9.31 | 8.05 |
| Net Sales Growth(%) | 0 | 13.06 | 9.5 | 26.83 | 15.53 | 13.45 | 19.91 | 16.5 | -11.06 |
| EBIT Growth(%) | 0 | -14.42 | -11.79 | 44.51 | 57.32 | 44.09 | 14.67 | 2.22 | -47.99 |
| PAT Growth(%) | 0 | -23.57 | -53.4 | 111.44 | 117.29 | 49.68 | 38.16 | -3.13 | -53.18 |
| EPS Growth(%) | 0 | -23.57 | -39.03 | 111.44 | 117.29 | 49.67 | -6.37 | -3.13 | -53.18 |
| Debt/Equity(x) | 1.37 | 1.14 | 2.01 | 1.74 | 1.49 | 1.11 | 0.32 | 0.25 | 0.22 |
| Current Ratio(x) | 1.12 | 1.2 | 1.25 | 1.32 | 1.5 | 1.6 | 2.85 | 2.63 | 2.65 |
| Quick Ratio(x) | 0.63 | 0.73 | 0.83 | 0.95 | 1.09 | 1.18 | 2.33 | 2.06 | 1.84 |
| Interest Cover(x) | 4.14 | 3.12 | 1.76 | 2.14 | 3.56 | 4.2 | 4.7 | 8.25 | 4.64 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0.13 | 0.14 | 0.29 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 59.39 | 59.39 | 59.39 | 59.39 | 59.39 | 59.39 | 59.39 | 59.41 | 59.41 | 59.42 |
| FII | 3.14 | 0.05 | 0.14 | 0.04 | 0.01 | 0.01 | 0.01 | 0.19 | 0 | 0 |
| DII | 1.82 | 1.41 | 1.41 | 1.3 | 1.3 | 1.24 | 1.24 | 1.24 | 1.08 | 1.08 |
| Public | 35.66 | 39.16 | 39.07 | 39.27 | 39.3 | 39.37 | 39.35 | 39.16 | 39.5 | 39.5 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 5.49 | 5.49 | 5.49 | 5.49 | 5.49 | 5.49 | 5.49 | 5.5 | 5.5 | 5.5 |
| FII | 0.29 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 |
| DII | 0.17 | 0.13 | 0.13 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.1 | 0.1 |
| Public | 3.3 | 3.62 | 3.61 | 3.63 | 3.64 | 3.64 | 3.64 | 3.62 | 3.65 | 3.65 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9.25 | 9.25 | 9.25 | 9.25 | 9.25 | 9.25 | 9.25 | 9.25 | 9.25 | 9.25 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -11% | +7% | +10% | — |
| Operating Profit CAGR | -40% | -12% | +8% | — |
| PAT CAGR | -52% | -13% | +17% | — |
| Share Price CAGR | -54% | — | — | — |
| ROE Average | +6% | +14% | +23% | +23% |
| ROCE Average | +8% | +15% | +21% | +21% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 59.39 | 59.39 | 59.39 | 59.39 | 59.39 | 59.39 | 59.39 | 59.41 | 59.41 | 59.42 |
| FII | 3.14 | 0.05 | 0.14 | 0.04 | 0.01 | 0.01 | 0.01 | 0.19 | 0 | 0 |
| DII | 1.82 | 1.41 | 1.41 | 1.3 | 1.3 | 1.24 | 1.24 | 1.24 | 1.08 | 1.08 |
| Public | 35.66 | 39.16 | 39.07 | 39.27 | 39.3 | 39.37 | 39.35 | 39.16 | 39.5 | 39.5 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 5.49 | 5.49 | 5.49 | 5.49 | 5.49 | 5.49 | 5.49 | 5.5 | 5.5 | 5.5 |
| FII | 0.29 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 |
| DII | 0.17 | 0.13 | 0.13 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.1 | 0.1 |
| Public | 3.3 | 3.62 | 3.61 | 3.63 | 3.64 | 3.64 | 3.64 | 3.62 | 3.65 | 3.65 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9.25 | 9.25 | 9.25 | 9.25 | 9.25 | 9.25 | 9.25 | 9.25 | 9.25 | 9.25 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.